Your browser doesn't support javascript.
loading
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression.
Molina, Oscar; Ortega-Sabater, Carmen; Thampi, Namitha; Fernández-Fuentes, Narcís; Guerrero-Murillo, Mercedes; Martínez-Moreno, Alba; Vinyoles, Meritxell; Velasco-Hernández, Talía; Bueno, Clara; Trincado, Juan L; Granada, Isabel; Campos, Diana; Giménez, Carles; Boer, Judith M; den Boer, Monique L; Calvo, Gabriel F; Camós, Mireia; Fuster, Jose-Luis; Velasco, Pablo; Ballerini, Paola; Locatelli, Franco; Mullighan, Charles G; Spierings, Diana C J; Foijer, Floris; Pérez-García, Víctor M; Menéndez, Pablo.
Afiliación
  • Molina O; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain. omolina@carrerasresearch.org.
  • Ortega-Sabater C; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain. omolina@carrerasresearch.org.
  • Thampi N; Mathematical Oncology Laboratory, Department of Mathematics & Institute of Applied Mathematics in Science and Engineering, Universidad de Castilla-La Mancha, Ciudad Real, Spain.
  • Fernández-Fuentes N; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
  • Guerrero-Murillo M; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain.
  • Martínez-Moreno A; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
  • Vinyoles M; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain.
  • Velasco-Hernández T; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
  • Bueno C; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain.
  • Trincado JL; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
  • Granada I; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain.
  • Campos D; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
  • Giménez C; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain.
  • Boer JM; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
  • den Boer ML; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain.
  • Calvo GF; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
  • Camós M; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain.
  • Fuster JL; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
  • Velasco P; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain.
  • Ballerini P; Hematology Service, Institut Català d'Oncologia (ICO)-Hospital Germans Trias i Pujol, Badalona, Spain.
  • Locatelli F; Josep Carreras Leukemia Research Institute, Autonomous University of Barcelona, Badalona, Spain.
  • Mullighan CG; DiNA Science, S.A, Barcelona, Spain.
  • Spierings DCJ; DiNA Science, S.A, Barcelona, Spain.
  • Foijer F; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Pérez-García VM; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Menéndez P; Department of Pediatric Oncology and Hematology, Erasmus Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands.
EMBO Mol Med ; 16(1): 64-92, 2024 Jan.
Article en En | MEDLINE | ID: mdl-38177531
ABSTRACT
Chromosomal instability (CIN) lies at the core of cancer development leading to aneuploidy, chromosomal copy-number heterogeneity (chr-CNH) and ultimately, unfavorable clinical outcomes. Despite its ubiquity in cancer, the presence of CIN in childhood B-cell acute lymphoblastic leukemia (cB-ALL), the most frequent pediatric cancer showing high frequencies of aneuploidy, remains unknown. Here, we elucidate the presence of CIN in aneuploid cB-ALL subtypes using single-cell whole-genome sequencing of primary cB-ALL samples and by generating and functionally characterizing patient-derived xenograft models (cB-ALL-PDX). We report higher rates of CIN across aneuploid than in euploid cB-ALL that strongly correlate with intraclonal chr-CNH and overall survival in mice. This association was further supported by in silico mathematical modeling. Moreover, mass-spectrometry analyses of cB-ALL-PDX revealed a "CIN signature" enriched in mitotic-spindle regulatory pathways, which was confirmed by RNA-sequencing of a large cohort of cB-ALL samples. The link between the presence of CIN in aneuploid cB-ALL and disease progression opens new possibilities for patient stratification and offers a promising new avenue as a therapeutic target in cB-ALL treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Aneuploidia Tipo de estudio: Risk_factors_studies Límite: Animals / Child / Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2024 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Aneuploidia Tipo de estudio: Risk_factors_studies Límite: Animals / Child / Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2024 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido